---
title: "Simvastatin - Familial type 3 hyperlipoproteinemia"
sidebar: mydoc_sidebar
permalink: simvastatinfamilialtype3hyperlipoproteinemia.html
toc: false 
---

{% include image.html url="images/simvastatinfamilialtype3hyperlipoproteinemia.png" file="simvastatinfamilialtype3hyperlipoproteinemia.png" alt="simvastatinfamilialtype3hyperlipoproteinemia" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D019821 | Simvastatin | Drug |
| UniProt:P04035 | HMG-CoA reductase | Protein |
| MESH:D001055 | Apolipoprotein B (apoB) | ChemicalSubstance |
| MESH:D006952 | Familial type 3 hyperlipoproteinemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Simvastatin | DECREASES ACTIVITY OF | Hmg-Coa Reductase |
| Hmg-Coa Reductase | DECREASES ABUNDANCE OF | Apolipoprotein B (Apob) |
| Apolipoprotein B (Apob) | CONTRIBUTES TO | Familial Type 3 Hyperlipoproteinemia |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00641#mechanism-of-action](https://go.drugbank.com/drugs/DB00641#mechanism-of-action){:target="_blank"}